SECOND‐STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA—CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL | Zendy

Payne Laura A. | Zendy; White Kamila S. | Zendy; Gallagher Matthew W. | Zendy; Woods Scott W. | Zendy; Shear M. Katherine | Zendy; Gorman Jack M. | Zendy; Farchione Todd J. | Zendy; Barlow David H. | Zendy

Premium

SECOND‐STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA—CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL

Author(s) -

Payne Laura A.,

White Kamila S.,

Gallagher Matthew W.,

Woods Scott W.,

Shear M. Katherine,

Gorman Jack M.,

Farchione Todd J.,

Barlow David H.

Publication year - 2016

Publication title -

depression and anxiety

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.634

H-Index - 129

eISSN - 1520-6394

pISSN - 1091-4269

DOI - 10.1002/da.22457

Subject(s) - panic disorder , agoraphobia , citalopram , randomized controlled trial , cognitive behavioral therapy , paroxetine , discontinuation , panic , psychiatry , psychology , medicine , clinical psychology , antidepressant , anxiety

Cognitive behavioral therapy (CBT) and pharmacotherapy are efficacious for the short-term treatment of panic disorder. Less is known about the efficacy of these therapies for individuals who do not respond fully to short-term CBT.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research